Kevin Shannon

Kevin Shannon is a Professor at the University of California San Francisco, where he serves as a physician-scientist. His research program focuses on hematopoietic growth control, genetic mechanisms of leukemogenesis, Ras signaling in cancer, and molecular therapeutics. He previously directed the Medical Scientist Training Program (MSTP) from 2006–2012.

• Education: A.B. in Biology from Williams College (1976), M.D. from Cornell University (1979), Residency in Pediatrics at University of Texas Southwestern (1982), Postdoctoral Fellowship in Hematology/Oncology at UCSF (1988)

His research spans Ras pathway mutations, mouse cancer models, and targeted therapies. Recent work highlights NRAS palmitoylation as a therapeutic target and MEK inhibition for RAS-associated cancers. Key collaborators include institutions like the Alex’s Lemonade Stand Foundation and NIH.

Scientific awards include the National Cancer Institute MERIT Award (2010), American Cancer Society Research Professorship (2016), and Team Science Award (2019). Current grants include NIH SPORE and RAF Dimer Inhibitor Treatment funding.